PDF 2018 DOWNLOADS



17th JANUARY, AFTERNOON SESSION
     14:30    Welcome and introduction (G. Di Perri)
     SESSION I - CLINICAL PHARMACOLOGY OF ANTIRETROVIRALS (Chair: G. Di Perri, C. Mussini)
     15:00    How clinical pharmacology can inform the clinicians (M. Boffito) download
     15:30    InSTI: evolution of clinical and pharmacological characteristics (S. Khoo) download
     16:00    Insight the backbone: new paradigms or new opportunities? (S. Bonora) download
     16:30    Coffee break
     17:00    Management of polypharmacy in the HIV aging patient (C. Marzolini) download
     17:30    Development of HIV and HCV drug interactions websites: story and perspectives (D. Back) download
     18:00    Clinical notes: Management of drug-drug interactions (C. Alcantarini, C. Montrucchio, L. Trentini) download

     19:00    Closing Day 1 Remarks


18th JANUARY, MORNING SESSION
    SESSION II - LOOKING FORWARD NEW STANDARDS FOR HIV TREATMENT (M. Andreoni, G. Nunnari)
     09:00    What is the magic number? Clinical Pharmacology of non-conventional regimens (G. Di Perri) download
     09:30    Treatment of HIV with long-acting agents: how far is it? (C. Flexner) download
     10:00    Welcome to the nanoworld (A. Owen) download
     10:30    Coffee break
     SESSION III - THE ROLE OF CLINICAL PHARMACOLOGY IN SUPPORTING THE CLINICIANS (D. Cattaneo, R. Garraffo)
     11:00    Prediction of dosing and drug-drug interactions (M. Siccardi) download
     11:30    Clinical pharmacology to support HIV clinicians in developing countries (M. Lamorde) download
     12:00    Which TDM in 2018?
                         - The support of the pharmacology lab (A. D’Avolio) download
                         - The clinical needs (L. Marinaro) download
     13:00    Lunch


18th JANUARY, AFTERNOON SESSION
    SESSION IV a - THE LANDSCAPE OF THE HCV TREATMENT (D. Back, G. Saracco)
     14:00    Are really all patients easy-to-treat nowadays? (S. Bhagani) download
     14:30    Sustainability of global HCV cure (A. Hill) download
     15:00    Clinical pharmacology of DAAs (G. Di Perri) download
     15:30    Coffee break
    SESSION IV b - HCV AND HBV: SIMPLIFICATION AND MONITORING (V. Ghisetti, C.F. Perno)
     16:00    Which role for the virologist in next future? (F. Ceccherini-Silberstein) download
     16:30    Do drug-drug interactions still matter with new regimens? (S. Bonora) download
     17:00    Beyond the HIV cure: stiffness, steatosis and fibrosis (R. Bruno) download
     17:30    Clinical notes: management of HBV infection (L. Boglione) download
     17:45    Closing Day 2 Remarks


19th JANUARY, MORNING SESSION
     09:00    Chairman: G. Di Perri
         Lecture “The discovery of Delta virus” (M. Rizzetto)
    SESSION V - NEW FRONTIERS (M. Galli, A. Marzano)
     09:30    Pharmacokinetics and pharmacodynamics of ARVs in lymphatic and gut tissues: a role for HIV eradication? (C. Fletcher) download
     10:00    Perspectives of treatment and cure of HBV infection (M.R. Brunetto) download
     10:30    Do we still need of new anti-HCV compounds? (M. Puoti) download
     11:00    Coffee break
    SESSION VI – CNS AND HIV (A. Antinori, P. Cinque)
     11:30    Management of neurocognitive impairment in HIV infection: a cases-based discussion (A. Calcagno, S. Letendre) download
     12:30    Closing Remarks (G. Di Perri)
     13:00    CME test